certainly a really good positive read. the trials indicate the huge potential of Bio A
hang in there troops, the end of the Opes tunnel must be soon and then the focus will fall squarely on ropren penetration (surely the initial supplies must be nearly finalised?) and in due course, getting some further trials and results to push Bio A into the pharma space.
